- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 691751 middle dose
Total 153 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimWithdrawn
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompletedHepatitis C, ChronicFrance, Germany, Switzerland
-
Boehringer IngelheimCompleted
-
Beijing Northland Biotech. Co., Ltd.CompletedAcute Myocardial InfarctionChina
-
Beijing Northland Biotech. Co., Ltd.CompletedSafety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.InfarctionAcute Myocardial InfarctionChina
-
Indonesia UniversityMedika Natura Sdn BhdCompleted
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingAdvanced Solid TumorsChina
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Boehringer IngelheimCompletedSchizophreniaSpain, Korea, Republic of, United Kingdom, Taiwan, United States, Austria, Italy, Germany, Poland, Japan, Canada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveGermany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedAlzheimer DiseaseSpain, United Kingdom, Italy, United States, Canada, Germany, Greece, Austria, Norway, France, Japan, Hungary, Poland, Finland
-
Advenchen Pharmaceuticals, LLC.RecruitingSmall Cell Lung CancerUnited States
-
Boehringer IngelheimCompleted
-
University of RoehamptonRecruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedPainful Diabetic Peripheral NeuropathyGermany, Hungary, Poland
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
AbbVieBoehringer IngelheimCompletedPsoriasisUnited States, Germany, United Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityEureka Therapeutics Inc.Unknown
-
PfizerTerminatedParkinson DiseaseUnited States, Spain, Canada, France, Japan, Germany
-
Santen Inc.CompletedOcular Hypertension | Open-angle GlaucomaUnited States
-
Jiangsu Province Centers for Disease Control and...Academy of Military Medical Sciences,Academy of Military Sciences,PLA; ZHONGYIANKE... and other collaboratorsRecruiting
-
Zhejiang UniversityNot yet recruitingHemophilia B Without Inhibitor
-
Affiliated Hospital of Guangdong Medical UniversityNot yet recruitingHemophilia B Without Inhibitor
-
AIM Vaccine Co., Ltd.Shulan (Hangzhou) Hospital; Yuncheng Central HospitalActive, not recruiting
-
Kyowa Kirin Co., Ltd.Completed
-
PfizerCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthyAustralia, South Africa
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Rob ErskineUniversity of East AngliaCompletedDiet | Nutrition | FoodUnited Kingdom
-
University of ChicagoMerck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Terence FlotteMassachusetts General Hospital; University of Massachusetts, WorcesterActive, not recruitingTay-Sachs Disease | Sandhoff DiseaseUnited States
-
Basilea PharmaceuticaArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedSolid TumorUnited States, Italy
-
Pauline VerdijkWorld Health OrganizationCompleted
-
Sylentis, S.A.CompletedChoroidal Neovascularization | Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersSpain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan